Related Experiment Video
Updated: Nov 7, 2025

CO2-Lasertonsillotomy Under Local Anesthesia in Adults
Published on: November 6, 2019
Nasal Sprays Containing Mometasone Furoate for Relief of Post-Adenotonsillectomy Pain in Children: A Prospective
Ozlem Unsal1, Meltem Akpinar1, Gulpembe Bozkurt2
1Department of Otorhinolaryngology Head and Neck Surgery, University of Health Sciences Turkey, Sisli Hamidiye Etfal Teaching and Research Hospital, Istanbul, Turkey.
Insights
Steroid nasal spray applied post-tonsillectomy significantly reduced pain on postoperative day 5. This finding offers a potential new strategy for managing post-tonsillectomy pain in children.
Area of Science:
- Otolaryngology
- Pediatric Surgery
- Pain Management
Background:
- Adenotonsillectomy is a common pediatric surgery.
- Post-tonsillectomy pain management remains a clinical challenge.
- Current strategies lack a universally effective approach.
Purpose of the Study:
- To evaluate the analgesic efficacy of steroid-containing nasal spray applied to the tonsillar region after tonsillectomy.
- To investigate a novel method for improving post-operative pain control.
Main Methods:
- A randomized study involving 82 pediatric patients undergoing tonsillectomy.
- The study group received steroid nasal spray on tonsillar regions for 5 days post-surgery.
- Pain was assessed using a visual analog scale and compared between groups.
Main Results:
- Pain scores decreased over time in both groups.
- While not significant from 4 hours to day 5, the steroid nasal spray group showed statistically significant pain reduction on postoperative day 5 (p<0.05).
Conclusions:
- Post-tonsillectomy pain often peaks around day 5 due to wound inflammation.
- Steroid nasal spray demonstrated clinical significance in reducing this late-phase pain.
- This intervention may offer an effective solution for managing post-tonsillectomy pain.
Objectives:
Adenotonsillectomy is one of most common surgeries performed in childhood. Post-operative pain associated particularly with tonsillectomy is still a problem for many physicians. Despite advances in surgical techniques, analgesics, or anti-inflammatory drugs, no unique strategy for post-tonsillectomy pain management has been suggested. The aim of this study is to investigate the analgesic effect of steroid containing nasal spray applied to tonsillar region after tonsillectomy.
Methods:
Eighty-two patients were assigned into two groups as study and control. In study group, nasal spray containing steroid was applied to each tonsillar region after surgery for 5 days. Post-operative pain of all patients was assessed using a visual analog scale and results were compared.
Results:
Pain decreased gradually over time in both the study and control groups. Although the pain scores from 4 h post-surgery to post-operative day 5 were not found to significantly decrease in children that used nasal spray containing steroid, these patients developed less pain on post-operative day 5,with statistical significance (p<0.05).
Conclusion:
Post-tonsillectomy pain was reported to increase around post-operative day 5, which coincides with the time of intense wound inflammation. Therefore, significant pain reduction on post-operative day 5 observed in children that used nasal spray with steroid may have clinical importance for overcoming this problem.
Related Concept Videos
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Upper Respiratory Drugs: Decongestants
Most decongestants are readily available over-the-counter in...
Tonsillitis II: Management
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Suctioning the Nasopharyngeal Airway
Equipment Required
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...

